{"name": "Threshold Pharmaceuticals",
 "permalink": "threshold-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/threshold-pharmaceuticals",
 "homepage_url": "http://www.thresholdpharm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "cancer, tumors, cancer-treatment, biotech",
 "alias_list": "",
 "email_address": "ir@thresholdpharm.com",
 "phone_number": "650-474-8200",
 "description": "Tumor Treatments",
 "created_at": "Wed Oct 07 22:53:50 UTC 2009",
 "updated_at": "Thu Apr 12 04:51:30 UTC 2012",
 "overview": "\u003Cp\u003EThreshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. \u003C/p\u003E\n\n\u003Cp\u003EThis approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, they are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       51],
      "assets/images/resized/0006/1970/61970v1-max-150x150.png"],
     [[150,
       51],
      "assets/images/resized/0006/1970/61970v1-max-250x250.png"],
     [[150,
       51],
      "assets/images/resized/0006/1970/61970v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chief Executive Officer",
    "person":
     {"first_name": "Harold",
      "last_name": "E. Selick",
      "permalink": "harold-e-selick",
      "image": null}},
   {"is_past": false,
    "title": " Chief Medical Officer ",
    "person":
     {"first_name": "Tillman",
      "last_name": "Pearce",
      "permalink": "tillman-pearce",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0004/8543/48543v1-max-150x150.jpg"],
          [[160,
            239],
           "assets/images/resized/0004/8543/48543v1-max-250x250.jpg"],
          [[160,
            239],
           "assets/images/resized/0004/8543/48543v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": " Senior Director of Financial Planning and Analysis",
    "person":
     {"first_name": "David",
      "last_name": "Southern",
      "permalink": "david-southern",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$55M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://deals.venturebeat.com/2009/10/07/threshold-raises-35m-to-treat-tumors-after-financial-turmoil/",
    "source_description": "Threshold raises $35M to treat tumors after financial turmoil",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 10,
    "funded_day": 7,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/threshold-pharma-lands-20m-milestone-merck-kgaa/2012-04-11",
    "source_description": "Threshold Pharma lands $20M milestone from Merck KGaA",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 11,
    "investments":
     [{"company":
        {"name": "Merck KGaA",
         "permalink": "merck-kgaa",
         "image":
          {"available_sizes":
            [[[132,
               88],
              "assets/images/resized/0007/0436/70436v1-max-150x150.jpg"],
             [[132,
               88],
              "assets/images/resized/0007/0436/70436v1-max-250x250.jpg"],
             [[132,
               88],
              "assets/images/resized/0007/0436/70436v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "170 Harbor Way, Suite 300",
    "address2": "",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2005,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:THLD"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}